Sep 14, 2021 Mesa Laboratories has entered into an agreement to acquire Agena Bioscience in a $300,000,000 deal. Mesa Laboratories based at Lakewood, Colorado, United […]
Series B – Vanqua Bio
On Sep 14, 2021 Vanqua Bio closed a Series B round and raised $85,000,000 from Avoro Ventures, Eli Lilly, Omega Funds, OrbiMed, OUP (Osage University […]
Series D – AgBiome
On Sep 14, 2021 AgBiome closed a Series D round and raised $116,000,000 from Blue Horizon, Novalis LifeSciences, featuring lead investors Blue Horizon, Novalis LifeSciences. […]
Post-IPO Equity – Avalo Therapeutics
On Sep 14, 2021 Avalo Therapeutics closed a Post-IPO Equity round and raised $27,500,000 from investors, featuring lead investors . About the company: Avalo Therapeutics […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Series A – Enhance Fitness
On Sep 14, 2021 Enhance Fitness closed a Series A round and raised $3,000,000 from Global Ventures, featuring lead investors Global Ventures. About the company: […]
Series B – Tia
On Sep 14, 2021 Tia closed a Series B round and raised $100,000,000 from ACME Capital, Combine, Compound, Define Ventures, GingerBread Capital, Human Ventures, Lone […]
Series C – RecoveryOne
On Sep 14, 2021 RecoveryOne closed a Series C round and raised $33,000,000 from 7wire Ventures, Cigna Ventures, Cobalt Ventures, Leverage Health, TELUS Ventures, featuring […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Seed Round – Mae
On Sep 14, 2021 Mae closed a Seed round and raised $1,300,000 from Avestria Ventures, MBX Capital, Rhia Ventures, Social Starts, SteelSky Ventures, featuring lead […]
